36Q-15330-91376 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-04
Dose 1 — Moderna
2021-01-06
Registered in v-safe
2021-02-01
Dose 2 — Moderna
2021-02-02
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea, SARS-CoV-2 test negative — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Systemic reaction (other): Shortness of breath which I also felt after the first dose (this made me concerned so I got tested for Covid today as well but that was negative) · Healthcare visit (other): Went for Covid test due to shortness of breath but that returned negative

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-02
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-03
Survey response — days 1–6 daily, dose 2
MedDRA: Erythema, Lymphadenopathy, Swelling — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities

Free text: Severe axillary lymphadenopathy with swelling and erythema of the axilla extending almost to the biceps anteriorly

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-04
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness · Rash, not including the immediate area around the injection site

Free text: Axillary Lymphadenopathy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-05
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Good

Free text: Improving axillary adenopathy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-07
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-16
Survey response — day 42, dose 2
MedDRA: Tenderness — Feeling: Good

Free text: Continued intermittent axillary tenderness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-05
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-06-21
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-04	Moderna
2	2021-02-01	Moderna

Call center

1 call center case

1 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 3 — days 1–6 daily, dose 2

2021-02-02

Systemic reaction (other): Shortness of breath which I also felt after the first dose (this made me concerned so I got tested for Covid today as well but that was negative)

Healthcare visit (other): Went for Covid test due to shortness of breath but that returned negative

2021-02-03

Systemic reaction (other): Severe axillary lymphadenopathy with swelling and erythema of the axilla extending almost to the biceps anteriorly

2021-02-04

Systemic reaction (other): Axillary Lymphadenopathy

2021-02-05

Systemic reaction (other): Improving axillary adenopathy

Release 5 — day 42, dose 2

2021-03-16

Symptoms: Continued intermittent axillary tenderness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Dyspnoea	✓	✓	✓
HCVO	SARS-CoV-2 test negative	✓	✓	✓
SD	Tenderness	✓	✓	✓
SRO	Dyspnoea	✓	✓	✓
SRO	Erythema	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓
SRO	Swelling	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release